| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $226K | — | +402.2% |
| Cost of Revenue | $206K | — | +524.2% |
| R&D Expense | $563K | — | -6.3% |
| SG&A Expense | $1.0M | — | -2.4% |
| Operating Income | -$1.6M | — | +3.8% |
| Income Tax | $0 | — | — |
| Net Income | -$1.6M | — | +3.5% |
| EPS (Basic) | -$0.09 | — | +10.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $419K | -69.0% | -75.8% |
| Accounts Receivable | $16K | +0.0% | +300.0% |
| Inventory | $15K | -6.3% | -68.8% |
| Current Assets | $873K | -52.3% | -62.1% |
| Total Assets | $1.8M | -32.8% | -47.3% |
| Current Liabilities | $1.7M | +7.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$937K | — | -23.6% |
| +38.2% |
| Total Liabilities | $1.7M | +5.3% | +24.8% |
| Stockholders' Equity | $92K | -91.3% | -95.5% |